.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Moodys
Accenture
Cerilliant
Deloitte
Julphar
Mallinckrodt
Covington
Fish and Richardson

Generated: June 26, 2017

DrugPatentWatch Database Preview

TACE Drug Profile

« Back to Dashboard

What is the patent landscape for Tace, and what generic Tace alternatives are available?

Tace is a drug marketed by Sanofi Aventis Us and is included in three NDAs.

The generic ingredient in TACE is chlorotrianisene. There are four drug master file entries for this compound. Additional details are available on the chlorotrianisene profile page.

Summary for Tradename: TACE

Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: see list28
Clinical Trials: see list149
Patent Applications: see list4,271
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TACE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
TACE
chlorotrianisene
CAPSULE;ORAL008102-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
TACE
chlorotrianisene
CAPSULE;ORAL016235-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
TACE
chlorotrianisene
CAPSULE;ORAL011444-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
Baxter
Deloitte
Medtronic
Fish and Richardson
Mallinckrodt
Covington
US Department of Justice
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot